期刊文献+

灯盏细辛注射液的抗氧化作用 被引量:1

Antioxidant effect of Dengzhanxinxi injection
下载PDF
导出
摘要 目的探讨灯盏细辛注射液的抗氧化作用。方法对比50例门诊患者(存在胸闷、胸痛、头晕、肢体麻木、言语謇涩、中风偏瘫等症状)接受灯盏细辛注射液治疗前后血浆中的丙二醛,髓过氧化物酶和还原型谷胱甘肽浓度的差异。结果患者静脉滴注灯盏细辛注射液治疗90min后,血浆丙二醛、髓过氧化物酶明显降低[(1.2±0.3)±μmol/L比(1.5±0.3)μmol/L,P=0.0235;(200±48)μg/L比(223±43)μg/L,P=0.0132],还原型符胱甘肽浓度升高[(4.3±2.7)μmol/L比(3.4±1.7)±mol/L,P=0.0489]。结论灯盏细辛注射液可抑制体内氧自由基,升高还原物质含量,发挥抗氧化作用。 Objective To discuss the antioxidant effect of Dengzhanxinxi injection. Methods This study included 50 outpatients who had chest pain, dizziness, numbness, speech Jian astringent, stroke, paralysis and other symptoms before having fleabane injection treatment. Plasma malondialdehyde, medullary peroxidase (MPO) and reduced glutathione ( GSH ) concentration were detected. Results After treatment of Dengzhanxinxi injection, plasma malondialdehyde decreased[ ( 1. 2 +0.3) μmol/L vs ( 1.5+0.3) μmoL/L, P =0. 023 5] ; MPO concentration decreased [ (200+ 48)μg/L vs (223 +43) μg/L, P =0. 013 2] ; the GSH concentrationicreased[ (4.3 +2.7 )μ mol/L vs ( 3.4 + 1.7 ) μmol/L, P = 0. 048 9 ]. Conclusion Dengzhanxinxi can inhibit oxygen free radicals.
作者 程德梅 范谦
出处 《中国医药》 2014年第6期813-815,共3页 China Medicine
关键词 灯盏细辛注射液 丙二醛 髓过氧化物酶 还原型谷胱甘肽 Dengzhanxinxi injection Malondialdehyde Medullary peroxidase Reduced glutathione
  • 相关文献

参考文献15

  • 1Fan Q,Chen M,Fang X,et al. Aging might augment reactive oxygen species (ROS) formation and affect reactive nitrogen species (RNS) level after myocardial ischemia/reperfusion in both humans and rats[J]. Age (Dordr),2013,35(4):1017-1026.
  • 2Liu B, Chen Y, St Clair DK. ROS and p53: a versatile partnership[J].Free Radic Biol Med,2008,44(8):1529-1535.
  • 3Archer SL, Gomberg-Maitland M, Maitland ML, et al. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 02-sensing pathway at the intersection of pulmonary hypertension and cancer[J]. Am J Physiol Heart Circ Physiol,2008,294(2):H570-578.
  • 4Blagosklonny MV. Aging: ROS or TOR[J].Cell Cycle,2008,7(21):3344-3354.
  • 5Chen J, Gusdon AM, Thayer TC, et al. Role of increased ROS dissipation in prevention of T1D[J]. Ann N Y Acad Sci,2008,1150:157-166.
  • 6Csordás G, Hajnóczky G. SR/ER-mitochondrial local communication: calcium and ROS[J].Biochim Biophys Acta,2009,1787(11):1352-1362.
  • 7Hureau C, Faller P. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer′s disease[J].Biochimie,2009,91(10):1212-1217.
  • 8Jaquet V,Scapozza L,Clark RA, Krause KH, et al. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets[J]. Antioxid Redox Signal,2009,11(10):2535-2552.
  • 9Kohchi C,Inagawa H,Nishizawa T,et al.ROS and innate immunity[J].Anticancer Res,2009,29(3):817-821.
  • 10Pun PB, Lu J, Moochhala S.Involvement of ROS in BBB dysfunction[J].Free Radic Res,2009,43(4):348-364.

二级参考文献10

共引文献10

同被引文献12

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部